NEW YORK--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Citi’s 15th Annual BioPharma Virtual Conference, which will be webcast on Tuesday, September 8, 2020. Samit Hirawat, MD, EVP, Chief Medical Officer and Rupert Vessey, MA, BM BCh, FRCP, DPhil, EVP of Research and Early Development will answer questions about the company at 12:15 p.m. EDT.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200902005021/en/
Bristol Myers Squibb
Media:
media@bms.com
609-252-3345
Investor Relations:
Tim Power
609-252-7509
timothy.power@bms.com
Nina Goworek
908-673-9711
nina.goworek@bms.com
Source: Bristol Myers Squibb